Teenage boy confesses to mistakenly stealing bike to take care of siblings
Broadcaster warned after omitting honorific for first lady
S. Korea to tighten export controls on Russia, Belarus
Democratic Party of Korea’s beef with prosecutors, explained
Skepticism clouds roles of overseas Korean nationals in upcoming election
Korea OKs export of botulinum toxin developed by Huons GlobalBy 박한나
Published : Oct. 11, 2016 - 17:41
The move came after the Huons’ newly developed drug HU-014JU, which is designed to help smooth out forehead frown lines, got the green light from the Ministry of Food and Drug Safety for its first and second clinical trials in August.
“The product is set to enter the domestic market in 2018. We will push ahead with plans to get global approvals,” said Kim Wan-seop, senior executive at Huons Global.
The drug maker will also move forward with the treatment to win approval from the US Food and Drug Administration for its clinical trials next year.
Shares in the KOSDAQ-listed firm climbed 7.47 percent to close at 48,200 won.
By Park Han-na (email@example.com)
Doctors' counterarguments backfire
Russia sending NK food in return for arms: Seoul defense chief
Legality issues linger as nurses fill treatment void Tuesday